Angelini Moment 200mg Ibuprofen 36 Coated Tablets

Product details

Therapeutic indications
Moment is used in the treatment of pain of various origins and nature (headache, toothache, neuralgia, osteo-joint and muscle pain, menstrual pain). It is an adjuvant in the symptomatic treatment of fever and flu.

Dosage and method of use
Moment is administered in the following doses:

Adults and children over 12 years: 1-2 tablets, 2-3 times a day.

Do not exceed the dose of 6 tablets per day. Do not exceed the recommended dose; in particular elderly patients should follow the minimum dosages indicated above. Take the product on a full stomach.

Contraindications

Do not administer under the age of 12. Pregnancy and breastfeeding. Hypersensitivity to the active substance, to other antirheumatics (acetylsalicylic acid, etc.) or to any of the excipients. Active or severe gastroduodenal ulcer or other gastropathies. History of gastrointestinal bleeding or perforation related to previous active treatments or history of recurrent peptic ulcer / haemorrhage (two or more distinct episodes of proven ulceration or bleeding). Severe hepatic or renal insufficiency. Severe heart failure.

Special warnings
Use caution in those patients whose activity requires vigilance in case they notice drowsiness, dizziness or depression while taking ibuprofen. The use of the drug, as of any prostaglandin synthesis and cyclooxygenase inhibitor drug, is not recommended in women intending to become pregnant. Administration should be discontinued in women who have fertility problems 'or who are undergoing investigation of fertility'. The use of the medicinal product should be avoided concomitantly with NSAIDs, including selective COX-2 inhibitors.

Undesirable effects can be minimized by using the lowest effective dose for the shortest possible duration of treatment needed to control symptoms. Clinical studies and epidemiological data suggest that the use of ibuprofen, especially at high doses (2400 mg / day) and for long-term treatments, may be associated with a modest increased risk of arterial thrombotic events (e.g. myocardial infarction. or stroke).

Pregnancy and breastfeeding

Pregnancy

Inhibition of prostaglandin synthesis can negatively affect pregnancy and / or embryo / fetal development. Results of epidemiological studies suggest an increased risk of miscarriage and cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. The absolute risk of cardiac malformations increased from less than 1% to approximately 1.5%.

The risk was believed to increase with dose and duration of therapy. In animals, administration of prostaglandin synthesis inhibitors has been shown to cause an increase in pre- and post-implantation loss and embryo-fetal mortality. Furthermore, an increased incidence of various malformations, including cardiovascular, has been reported in animals administered prostaglandin synthesis inhibitors during the organogenetic period.

During the third trimester of pregnancy, all prostaglandin synthesis inhibitors can expose the fetus to: cardiopulmonary toxicity (with premature closure of the arterial duct and pulmonary hypertension); renal dysfunction, which can 'progress to renal failure with oligo-hydroamnios; the mother and the newborn.
At the end of pregnancy, to: possible prolongation of bleeding time, and antiplatelet effect which can occur even at very low doses; inhibition of uterine contractions resulting in delayed or prolonged labor.

Expiry and retention
Check the expiration date indicated on the package. The expiry date indicated on the package refers to the product in intact packaging, correctly stored. Store below 25 ° C.

Warning: do not use the medicine after the expiry date indicated on the package.

Composition
Moment Tablets contains:
Active ingredient: ibuprofen 200 mg
Excipients: l-arginine, sodium bicarbonate, sodium birtartrate, lactose, sodium saccharin, grapefruit flavor, crospovidone.